7 Questions to Ask Your Benefits Broker Before Your Next Renewal

November 6, 2026 • 4 mins

Before your next renewal, ask your broker how they're compensated, what alternative plan designs they modeled, what data is driving your specific increase, and what support they provide between renewals; the answers reveal whether your broker relationship is built on strategy or inertia.

Most employers don't question their broker relationship until something goes wrong, a bad renewal, a claims dispute, an HR team that's drowning in admin work. But renewal season is actually the best time to find out whether your current broker is set up to serve your interests or just to keep the relationship running. Here are seven questions worth asking, and what the answers actually reveal.

1. "How is your compensation structured, does it change based on which plan or carrier we choose, and how often do you transparently review your compensation?"

This is the single most important question, and the one most employers never ask. Traditional broker compensation is often commission-based, meaning the broker's revenue can rise when your premium rises. That's not necessarily bad faith, but it is a structural conflict of interest worth understanding. If your broker can't clearly explain how they're paid and whether it changes based on their recommendation, that's worth sitting with. Some newer brokerage models have moved toward flat-fee or transparent compensation structures specifically to remove this conflict. You want your broker to be completely aligned with your benefit goals as an organization, but also on the same page when it comes to your financial bottom line.

2. "What alternative funding or plan design options did you actually model for us this year, and can you walk us through the cost-benefit analysis for why you ruled them out?""

A good broker should be able to show you what they considered and ruled out, level-funded, a CHOICE Arrangement (formerly ICHRA), reference-based pricing, group captive models, unbundled/carve out options for self funded groups; not just what they're recommending. If the honest answer is "we renewed what you had last year," you're not getting a strategy, you're getting a rollover that’s simply maintaining the status quo and that’s not the type of consultative support you should expect from a broker partner.

3. "What specific data is driving our renewal increase, not just the industry trend?"

"Costs are up industry-wide" is true almost every year and explains almost nothing about your business's specific rate hike. A broker with visibility into your claims should be able to pinpoint the primary culprit—whether that’s a few catastrophic claims, a surge in specialty pharmacy (like GLP-1s), or shifting outpatient utilization.

(Note: If you have under 50–100 employees and are fully insured, carriers may restrict detailed claims data for HIPAA privacy reasons. In that case, your broker should still be able to demand and explain your group's aggregate Loss Ratio.)

If your broker only points to generic market trends, ask them why they don't have your group's specific data.

4. "Can we review our ongoing plan utilization data, and what specific strategy does this data point to - beyond just reviewing the renewal summary?"

Knowing which services, claims, and care settings are driving your spend is the difference between negotiating from a position of strategy and negotiating blind. A strong broker won't just hand you a dense annual PDF summary; they'll provide regular utilization reporting (or real-time dashboards) and translate that data into actionable plan tweaks.

For example, if your data shows high ER usage for non-emergencies or low generic pharmacy fills, your broker should proactively offer solutions—like targeted employee education or low-copay virtual care options.

(Tip: If your current fully-insured carrier refuses to share detailed utilization metrics, ask your broker if moving to a level-funded or self-funded model is appropriate for your group to gain that transparency.)

5. "What's your specific strategy for managing GLP-1 and specialty drug costs, not the carrier's default?"

A proactive advisor should have a clear point of view on independent prior authorization, biosimilar steering, and clinical support requirements to ensure claims are appropriate. If your broker's response to rising GLP-1 costs is "we're monitoring the market" or "we'll see what the carrier offers," they aren't managing your pharmacy spend—they're letting the carrier manage your budget.

6. "What do you actually do for us between renewals?"

If the honest answer is "not much until next year's renewal conversation," that's telling. A broker relationship built for the long term should include ongoing support: compliance monitoring, employee communication help, and someone to call when a claims issue comes up in March, not just November - this means providing proactive accountability throughout the year.You don’t want to be paying year round commissions, for a two month service.

7. "If we hire in a new state (or country), what changes about our plan and compliance obligations?"

Remote and distributed teams may be standard today, but multi-state benefits compliance remains a landmine. A single hire in a new state can trigger complex Paid Family & Medical Leave (PFML) mandates, local disability requirements, state mini-COBRA rules, and network adequacy issues (e.g., when a regional HMO doesn't cover a remote employee in another state).

Internationally, the rules shift entirely to local statutory benefits, international private medical insurance (IPMI), or Employer of Record (EOR) setups.

Ask your broker if they provide a proactive state-by-state compliance matrix and zip-code network audits as you expand. If you only find out about state mandates or broken network coverage after an employee files an out-of-network claim or an auditor comes knocking, your broker is operating in reactive mode.

Why these questions matter more than they seem to

Asking these questions isn't about setting your broker up to fail or creating unnecessary friction. It's about ensuring your organization's second or third largest line item is backed by deliberate strategy rather than pure inertia.

Too many companies stay with an underperforming broker simply because switching feels like a massive operational headache. But here’s the reality: changing your benefits advisor doesn't mean tearing up your current insurance plans or disrupting your employees' coverage—it simply changes who sits on your side of the table.

Benefit strategy shouldn't run on autopilot. Take these questions into your next renewal planning meeting. The depth, transparency, and speed of your broker’s answers will tell you everything you need to know about whether you have a true strategic partner—or just a vendor renewing last year's plan.

What "good" looks like

Strategic, modern benefits partners consistently share four core traits:

- Transparent Compensation: Clear, conflict-free fee structures instead of hidden carrier commissions.

- Real-Time Claims Access: Continuous visibility into your data, not a dense PDF once a year.

- Proactive Cost Strategies: Documented playbooks for high-impact spend like GLP-1s and specialty drugs.

- Year-Round Support: Dedicated tech, compliance, and employee advocacy that doesn't disappear between renewals, ultimately creating more work for your team.

We built Bennie around this exact framework—treating benefits management as a year-round, data-driven strategy and giving employers real-time control through tools like Bennie Insights. Whether or not you ever work with us, that's the benchmark worth holding your broker to.

About Bennie

Bennie is a modern employee benefits firm dedicated to transforming how employers design, manage, and deliver benefits. By combining world-class brokerage services with user-friendly technology, Bennie helps organizations lower costs and streamline administration while giving employees a centralized platform to navigate their healthcare. Headquartered in New York City, Bennie is licensed in all 50 states.

Previous Article Level-Funded vs. Fully Insured: Which Funding Strategy Makes Sense for 2027?

Related Articles